Key result
Downregulating NBCe1 increases cardiomyocyte area ~20%, inducing cardiac hypertrophy in rats.
Why the study?
The dysfunction of cardiac alkalinizing mechanisms is linked to cardiovascular disease, but the specific contribution of NBCe1 downregulation to cardiac hypertrophy was unknown.
Does specific downregulation of NBCe1 using AAV9-shRNA induce cardiac hypertrophy and modify electrical features in rat hearts?
Does specific downregulation of NBCe1 using AAV9-shRNA induce cardiac hypertrophy and modify electrical features in rat hearts?
Specific in vivo downregulation of the electrogenic sodium/bicarbonate cotransporter NBCe1 is sufficient to induce cardiac hypertrophy and prolong the QT interval in a normotensive rat model.
Answers are grounded in this paper and cite their sources.
Should not change practice; hypothesis-generating for NBCe1 as hypertrophy regulator in translational models.
Two alkalinizing mechanisms coexist in cardiac myocytes in order to maintain the intracellular pH: sodium/bicarbonate cotransporter (electroneutral isoform NBCn1 and electrogenic isoform NBCe1) and sodium/proton exchanger (NHE1). The dysfunction of these transporters has been previously reported as responsible for the development of cardiovascular diseases. The aim of this work was to evaluate the contribution of the downregulation of the NBCe1 to the development of cardiac hypertrophy. To specifically reduce NBCe1, we used shRNA cloned into a cardiotropic adeno-associated vector (AAV9-shNBCe1). After 28 days of being injected with AAV9-shNBCe1, the expression and the activity of NBCe1 in the rat heart were reduced. Strikingly, the downregulation of NBCe1 causes significant hypertrophic heart growth, lengthening of the action potential in isolated myocytes, increase in the duration of the QT interval and increase in the frequency of Ca 2+ waves without any significant changes in Ca 2+ transients. An increased compensatory expression of NBCn1 and NHE1 was also found. We conclude that the reduction of NBCe1 is sufficient to induce cardiac hypertrophy and modify electrical features of the rat heart.
No takes yet. Share an insight, caveat, or question.
Mattía et al. (2022) studied Cardiac Hypertrophy. AAV9-shNBCe1 vs. AAV9-shControl was evaluated on Cardiomyocyte cross-sectional area (CSA) (p=<0.05). Downregulation of NBCe1 by AAV9-shNBCe1 significantly increased cardiomyocyte cross-sectional area to 297.6 µm2 compared to 247.5 µm2 in controls, inducing cardiac hypertrophy in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: